Literature DB >> 29468477

Ethanol extract of Rehmannia glutinosa exerts antidepressant-like effects on a rat chronic unpredictable mild stress model by involving monoamines and BDNF.

Jun-Ming Wang1,2, Li-Xin Pei3, Yue-Yue Zhang3, Yong-Xian Cheng4, Chun-Ling Niu5, Ying Cui3,6, Wei-Sheng Feng7,8, Gui-Fang Wang3.   

Abstract

The dried roots of Rehmannia glutinosa Libosch. (Scrophulariaceae) are of both medicinal and nutritional importance. Our previous study has found that the 80% ethanol extract of R. glutinosa (RGEE) produced antidepressant-like activities in mouse behavioral despair depression models. However, its mechanisms are still unclear. The present study aimed to observe the antidepressant-like mechanisms of RGEE on a rat chronic unpredictable mild stress (CUMS) model by involving monoaminergic neurotransmitters and brain-derived neurotrophic factor (BDNF). CUMS-stressed rats were orally given RGEE daily (150, 300, and 600 mg/kg) or fluoxetine hydrochloride (FH) for 3 weeks after starting the CUMS procedure. Sucrose preference test was carried out to observe depression-like behavior, and serum and brain tissues were used for neurochemical and fluorescent quantitative reverse transcription PCR analysis. Results demonstrated that CUMS induced depression-like behavior, whereas RGEE and FH administration inhibited this symptom. Furthermore, CUMS caused excessively elevated levels of serum corticosterone (CORT), an index of hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, in a manner attenuated by RGEE and FH administration. RGEE administration also further elevated monoamine neurotransmitters and BDNF levels, up-regulated the mRNA expression of BDNF and tropomyosin-related kinase B (TrkB) in hippocampus of rats suffering CUMS. Together, our findings suggest that RGEE can improve CUMS-evoked depression-like behavior, and indicate its mechanisms may partially be associated with restoring HPA axis dysfunctions, enhancing monoamineergic nervous systems, and up-regulating BDNF and TrkB expression.

Entities:  

Keywords:  Antidepressant; BDNF; Chronic unpredictable mild stress; Monoamineergic nervous system; Rehmannia glutinosa

Mesh:

Substances:

Year:  2018        PMID: 29468477     DOI: 10.1007/s11011-018-0202-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  29 in total

1.  Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis.

Authors:  Zheng Mou; Qian Huang; Shi-Feng Chu; Mei-Jin Zhang; Jin-Feng Hu; Nai-Hong Chen; Jun-Tian Zhang
Journal:  Biomed Pharmacother       Date:  2017-06-10       Impact factor: 6.529

2.  Involvement of monoaminergic system in the antidepressant-like effect of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice.

Authors:  Francisca Cléa Florenço de Sousa; Iris Cristina Maia Oliveira; Maria Izabel Gomes Silva; Carla Thiciane Vasconcelos de Melo; Vívian Romero Santiago; Raquell de Castro Chaves; Mariana Lima Fernandes; Stanley Juan Chaves Gutierrez; Silvânia Maria Mendes Vasconcelos; Danielle Silveira Macêdo; José Maria Barbosa Filho
Journal:  Fundam Clin Pharmacol       Date:  2012-08-23       Impact factor: 2.748

3.  Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.

Authors:  Yuan-Yuan Tian; Li-Jia An; Lan Jiang; Yan-Long Duan; Jun Chen; Bo Jiang
Journal:  Life Sci       Date:  2006-09-20       Impact factor: 5.037

4.  Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram.

Authors:  Maria Ladea; Mihai Bran
Journal:  Psychiatr Danub       Date:  2013-06       Impact factor: 1.063

5.  Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair.

Authors:  Hai-Ling Yu; Lian-Ping Sun; Miao-Miao Li; Zhe-Shan Quan
Journal:  Neurosci Lett       Date:  2015-03-13       Impact factor: 3.046

6.  Unpredictable chronic mild stress induced behavioral deficits: a comparative study in male and female rats.

Authors:  Muhammad Farhan; Huma Ikram; Sumera Kanwal; Darakhshan Jabeen Haleem
Journal:  Pak J Pharm Sci       Date:  2014-07       Impact factor: 0.684

7.  HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.

Authors:  Masako Aihara; Itsuro Ida; Naoya Yuuki; Akihiko Oshima; Hiroshi Kumano; Keisuke Takahashi; Masato Fukuda; Noboru Oriuchi; Keigo Endo; Hiroshi Matsuda; Masahiko Mikuni
Journal:  Psychiatry Res       Date:  2007-06-22       Impact factor: 3.222

Review 8.  The HPA axis in major depression: classical theories and new developments.

Authors:  Carmine M Pariante; Stafford L Lightman
Journal:  Trends Neurosci       Date:  2008-07-31       Impact factor: 13.837

9.  Brain-derived neurotrophic factor: role in depression and suicide.

Authors:  Yogesh Dwivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

10.  Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders.

Authors:  M T Ray; C Shannon Weickert; M J Webster
Journal:  Transl Psychiatry       Date:  2014-05-06       Impact factor: 6.222

View more
  10 in total

1.  Catalpol Exerts Antidepressant-Like Effects by Enhancing Anti-oxidation and Neurotrophy and Inhibiting Neuroinflammation via Activation of HO-1.

Authors:  Xiaohui Wu; Chen Liu; Junming Wang; Yuechen Guan; Lingling Song; Rongxing Chen; Mingzhu Gong
Journal:  Neurochem Res       Date:  2022-06-06       Impact factor: 4.414

Review 2.  Interactions Among Brain-Derived Neurotrophic Factor and Neuroimmune Pathways Are Key Components of the Major Psychiatric Disorders.

Authors:  Nikolay Mehterov; Danail Minchev; Maria Gevezova; Victoria Sarafian; Michael Maes
Journal:  Mol Neurobiol       Date:  2022-06-03       Impact factor: 5.682

3.  Antidepressant-like effects of the Guanxin Danshen formula via mediation of the CaMK II-CREB-BDNF signalling pathway in chronic unpredictable mild stress-induced depressive rats.

Authors:  Weijie Xie; Xiangbao Meng; Yadong Zhai; Tianyuan Ye; Ping Zhou; Fengwei Nan; Guibo Sun; Xiaobo Sun
Journal:  Ann Transl Med       Date:  2019-10

4.  Optimization of food deprivation and sucrose preference test in SD rat model undergoing chronic unpredictable mild stress.

Authors:  Li-Wen He; Li Zeng; Na Tian; Yi Li; Tong He; Dong-Mei Tan; Qian Zhang; Yi Tan
Journal:  Animal Model Exp Med       Date:  2020-03-31

Review 5.  Chinese Herbal Medicine for the Treatment of Depression: Effects on the Neuroendocrine-Immune Network.

Authors:  Chan Li; Bishan Huang; Yuan-Wei Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-14

6.  Intranasal administration of white tea alleviates the olfactory function deficit induced by chronic unpredictable mild stress.

Authors:  Wenhao Hu; Guixiang Xie; Tian Zhou; Jialu Tu; Jiayi Zhang; Zejie Lin; Haiyang Zhang; Liangcai Gao
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

Review 7.  Extracellular Vesicles: Emerging Roles in Developing Therapeutic Approach and Delivery Tool of Chinese Herbal Medicine for the Treatment of Depressive Disorder.

Authors:  Qian Wu; Wen-Zhen Duan; Jian-Bei Chen; Xiao-Peng Zhao; Xiao-Juan Li; Yue-Yun Liu; Qing-Yu Ma; Zhe Xue; Jia-Xu Chen
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

8.  Identification and Functional Characterization of Tyrosine Decarboxylase from Rehmannia glutinosa.

Authors:  Yuanjun Li; Yanan Wang; Longyu Huang; Chunrong Chen; Na An; Xiaoke Zheng
Journal:  Molecules       Date:  2022-03-01       Impact factor: 4.411

Review 9.  Combination of Stem Cells with Chinese Herbs for Secondary Depression in Neurodegenerative Diseases Based on Traditional Chinese Medicine Theories.

Authors:  Jiahao Feng; Li Liao; Fangfang Xu; Lin Zhang; Jun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-03       Impact factor: 2.629

10.  Tao-Hong-Si-Wu decoction improves depressive symptoms in model rats via amelioration of BDNF-CREB-arginase I axis disorders.

Authors:  Xiaoping Zhang; Zeng Li; Chuanpu Shen; Jinzhi He; Longfei Wang; Lei Di; Bin Rui; Ning Li; Zhicheng Liu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.